Surrogate Outcomes and Patient Outcomes: Reading Regenerative-Medicine Claims Carefully

By the Regenerative Evidence Guide Team

A surrogate outcome is a lab value, scan, or biomarker used as a stand-in for a real health result. A patient outcome is the change a person actually lives — less pain, more mobility, or avoiding a later procedure. A regenerative-medicine claim can improve one without proving the other, so know which one a study reports before weighing any treatment decision.

Terms to Know: Surrogate Outcomes vs. Patient Outcomes

• Patient-important outcome: A change a person would notice and care about in daily life — such as less pain, more mobility, fewer flare-ups, or avoiding a future surgery.
• Surrogate outcome (also called an intermediate or proxy outcome): A measurement that stands in for a patient-important outcome, such as an imaging finding, a biomarker, or a lab value, used because it is faster or easier to measure than the final health result.
• Validated surrogate: A surrogate outcome shown, through separate research, to reliably predict a patient-important outcome. Not every surrogate meets this bar, and many used in early regenerative-medicine research have not been tested this rigorously.
• Statistical significance: A signal that a difference between groups is unlikely to be due to chance alone. It says nothing about how large or meaningful that difference is.
• Clinical significance: A measure of whether the size of an effect is large enough to matter in a person’s actual life, separate from whether it is statistically significant.

Surrogate Outcomes vs. Patient Outcomes: A Side-by-Side Look

NIH evidence-review methods guidance draws this distinction directly, using heart disease as its example: LDL cholesterol is an intermediate outcome, while a heart attack or a documented improvement in quality of life is a direct, patient-centered outcome. The same structure applies to regenerative-medicine claims.

• What a surrogate outcome measures: A biological marker, an imaging result, or a lab value believed to be connected to a health outcome — for example, tissue appearance on an MRI, a cell count, or an inflammation marker.
• What a patient outcome measures: A result the person lives — reduced pain during daily activity, returning to work or exercise, avoiding a joint replacement, or a documented change in function over time.
• Why the surrogate is used: It can often be measured sooner, in smaller numbers of people, and at lower cost than waiting years to see whether patients’ function actually changes.
• What the surrogate cannot promise on its own: A better-looking scan or marker does not commitment a person will feel or function better, because the two are not always as closely linked as they appear.
• What closes the gap: Research that directly tracks patient-important outcomes over time, or that has already established a strong, tested link between the specific surrogate and the specific outcome in question.

Why Do Researchers Use Surrogate Measures at All?

Surrogate outcomes are not a shortcut taken in bad faith. NIH evidence-review guidance notes that researchers turn to intermediate measures when a final health outcome would take a long time to occur, when that outcome is rare and hard to observe in a study of manageable size, or when practical constraints make direct measurement difficult. A well-chosen surrogate outcome can point toward promising treatments earlier, before a large, multi-year trial is feasible. The issue is not that surrogate outcomes exist — it’s that not every surrogate outcome has been studied for its potential to predict the patient outcome people actually care about.

The Gap Between a Better Scan and a Better Life

NIH guidance is direct about this gap: intermediate outcomes need “clear, strong associations with health outcomes” before they can be treated as trustworthy stand-ins, and reviews that rely on them are expected to explain why the surrogate was included and to acknowledge the uncertainty between the marker and the actual patient benefit. A study can be well-designed and still leave an open question if the outcome it reports is a surrogate rather than a lived result. That is not a reason to dismiss the research — it is a reason to note what was measured before drawing a conclusion about what it means for recovery.

A Field Guide: Five Questions to Ask About Any Regenerative-Medicine Claim

1. What was actually measured? Look for the specific word used to describe the result — a scan, a marker, a score, or a lived outcome like pain, mobility, or return to activity.
2. Is that measurement a surrogate outcome? If the result is a biomarker, an imaging finding, or a lab value rather than something the patient would notice day to day, treat it as a surrogate outcome until shown otherwise.
3. Has this surrogate outcome been linked to patient outcomes before? A surrogate with a long track record of predicting real-world benefit carries more weight than one used for the first time in a small study. How to Read a Regenerative-Medicine Study walks through the related checks on study design and participant details.
4. Is the improvement statistically significant, clinically significant, or both? Per NIH’s National Center for Complementary and Integrative Health, a result can be statistically real but too small to matter in daily life — the size of the effect matters as much as whether it was detected at all.
5. Does the source compare this finding to other research? A single study, even a well-designed one, is rarely the final word. Guidance on reading scientific results recommends checking whether findings have been repeated by other researchers with different participants.

A simple decision path: If a claim reports only a scan result, a biomarker, or a lab value, treat it as preliminary until patient-outcome data exists. If a claim reports pain relief, mobility, or return-to-activity data collected and compared over time, it is closer to a genuine patient outcome — though it should still be checked against the other four questions above.

Is Statistical Significance the Same as Feeling Better?

No — and this is one of the most useful distinctions in evaluating any claim in this field. Statistical significance means the difference seen between groups probably was not due to random chance. Clinical significance is a separate question: how big is that difference, and would a person actually notice it? A regenerative-medicine study can report a statistically significant change in a marker while the real-world difference in how patients feel is small or unclear.

What This Page Is Not

This page does not evaluate, recommend, or rank any specific regenerative-medicine procedure, product, clinic, or provider, and it is not a substitute for a conversation with a qualified clinician about your own health. It does not diagnose any condition or tell you whether to start, stop, delay, or pursue any treatment. If you are facing a medical emergency, contact local emergency services immediately rather than searching for information online.

Where to Go Next

If you’re looking at a specific trial listed online, How to Read a Clinical Trial Record Before You Contact a Research Team explains how to interpret the terminology and status fields you’ll encounter.

Sources and Verification

This page draws on the National Institutes of Health’s evidence-review methods guidance on intermediate and patient-centered outcomes, and on the National Center for Complementary and Integrative Health’s guidance on reading the results section of a scientific journal article. See How We Research for this site’s sourcing and review process. This page reflects general research-literacy concepts and does not represent findings specific to any individual product, procedure, or provider.

This article is educational information only and is not medical advice, a diagnosis, or a treatment recommendation. Regenerative Evidence Guide is an independent educational publication and is not affiliated with any clinic, academy, faculty, conference, or training program formerly associated with this domain. Always talk with a qualified healthcare provider about your own situation.

By Regenerative Evidence Guide Editorial Team. Last updated September 8, 2026.